Wire · opportunities
Innovations in reagent manufacturing to support the global diagnostics supply chain
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
The article discusses innovations in distributed and local manufacturing of biological reagents to improve access to in-vitro molecular diagnostics in low- and middle-income countries, addressing supply chain limitations exposed during the COVID-19 pandemic and proposing sustainable economic models for reagent production.
This Wire brief sits within Fusion42's coverage of Diagnostics.
◆ ◆ The Wire takeaway
You can tap into the urgent need for local reagent production in emerging markets where supply chains failed during COVID-19. Building upstream manufacturing capacity near your customers could bypass costly imports and create durable market access.
◆ Coverage
1 source · 31 Aug 2026
◆ Related on Wire
◆ Topics